Journal
BIOTECHNOLOGY ADVANCES
Volume 31, Issue 4, Pages 482-488Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.biotechadv.2013.01.010
Keywords
Bacteriocins; Bifidobacterium spp.; Antimicrobial compounds; Lactic acid bacteria
Categories
Funding
- CAPES
- FAPESP [2011/50195-7, 2011/14048-0]
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [11/14048-0] Funding Source: FAPESP
Ask authors/readers for more resources
Bacteriocins are ribosomally-synthesized antibacterial peptides. These compounds are produced by a broad variety of different bacteria belonging mainly to the genus Bifidobacterium, to which health promoting properties have frequently been attributed. However, despite the fact that the identification of Bifidobacterium-associated bacteriocins was first reported in 1980 and that they exhibit antimicrobial activity against pathogenic microorganisms such as Listeria monocytogenes, Clostridium perfringens, and Escherichia colt, relatively little information is still available about the antimicrobial compounds produced by strains of this genus. More detailed understanding of the action mechanisms of these antimicrobials could allow us to determine the extent to which their production contributes to the probiotic properties of specific bifidobacteria strains and, potentially, be of crucial significance for ultimate preservation of functional foods or pharmaceutical applications. Here we review what is already known about their structure, classification, mode of action, functionality, immunity, production and purification. (C) 2013 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available